|
Market Closed -
Euronext Paris
16:55:00 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3950 EUR | -3.19% |
|
-20.20% | +186.23% |
| 10-12 | Valerio Therapeutics Finalizes Purchase of Etherna Immunotherapies | MT |
| 10-07 | Valerio Therapeutics Société anonyme completed the acquisition of eTheRNA immunotherapies NV. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 227M | - | - | - | - | - |
| 1,077B | |||||
| 612B | |||||
| 501B | |||||
| 364B | |||||
| 353B |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
